China Resources Pharmaceutical Group Ltd. held its Annual General Meeting on 23 May 2025. Proposals included the re-election of Mr. Bai Xiaosong as an executive director, which was approved. The appointment of Mdm. Chiu Mun Wai and Mr. Shi Luwen as independent non-executive directors was also approved. Additionally, the proposal to amend the composition of board committees was approved.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.